KHRNF OTC
Khiron Life Sciences Corp.
1W: +900.0%
1M: +900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$13M
+59.6% ▲
Gross Profit
$6M
-9.1% ▼
Operating Income
-$20M
+16.2% ▲
Net Income
-$33M
-37.8% ▼
EPS (Diluted)
$-0.20
+0.0% ▲
EBITDA
-$32M
-40.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $892K | $10M | $8M | $13M |
| YoY Growth | +0.0% | +0.0% | +974.6% | -16.3% | +59.6% |
| Cost of Revenue | $0 | $594K | $7M | $1M | $6M |
| Gross Profit | $0 | $297K | $2M | $7M | $6M |
| Gross Margin | — | 33.3% | 25.4% | 87.4% | 49.8% |
| R&D Expenses | $0 | $0 | $4M | $2M | $1M |
| SG&A Expenses | $0 | $20M | $36M | $28M | $24M |
| Operating Expenses | $0 | $20M | $40M | $31M | $26M |
| Operating Income | $0 | -$20M | -$37M | -$24M | -$20M |
| Operating Margin | — | -2231.3% | -390.6% | -294.4% | -154.6% |
| Interest Expense | $0 | $0 | $0 | $468K | $445K |
| Income Before Tax | $0 | -$20M | -$36M | -$24M | -$34M |
| Tax Expense | $0 | $79K | $23K | $89K | -$465K |
| Net Income | $0 | -$20M | -$36M | -$24M | -$33M |
| Net Margin | — | -2221.3% | -379.6% | -299.8% | -258.9% |
| EPS (Diluted) | $-0.16 | $-0.41 | $-0.36 | $-0.20 | $-0.20 |
| EBITDA | -$4M | -$18M | -$36M | -$23M | -$32M |
| Shares Outstanding | 28M | 49M | 102M | 120M | 165M |